Clinical Trials Directory

Trials / Sponsors / WiSP Wissenschaftlicher Service Pharma GmbH

WiSP Wissenschaftlicher Service Pharma GmbH

Academic / Other · 8 registered clinical trials.

StatusTrialPhaseStarted
UnknownCarboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer
Ovarian Cancer
Phase 22011-10-01
UnknownPanitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Cli
Rectal Cancer
Phase 22010-12-01
TerminatedPURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer
Urinary Bladder Cancer
Phase 22010-07-01
SuspendedPanitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With
Carcinoma, Non-Small-Cell Lung
Phase 22010-04-01
CompletedPredictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy
Hodgkin's Disease, Non-Hodgkin Lymphomas, Multiple Myelomas
Phase 2 / Phase 32003-05-01
CompletedBendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia
Phase 2 / Phase 32001-09-01
CompletedTandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy
Multiple Myeloma
Phase 32001-08-01
CompletedWeekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer
Metastatic Breast Cancer
Phase 22001-02-01